Helmut Oettle

12.5k total citations · 3 hit papers
149 papers, 8.2k citations indexed

About

Helmut Oettle is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Helmut Oettle has authored 149 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 38 papers in Surgery. Recurrent topics in Helmut Oettle's work include Pancreatic and Hepatic Oncology Research (82 papers), Cancer Genomics and Diagnostics (35 papers) and Colorectal Cancer Treatments and Studies (28 papers). Helmut Oettle is often cited by papers focused on Pancreatic and Hepatic Oncology Research (82 papers), Cancer Genomics and Diagnostics (35 papers) and Colorectal Cancer Treatments and Studies (28 papers). Helmut Oettle collaborates with scholars based in Germany, United States and Italy. Helmut Oettle's co-authors include Hanno Riess, P. Neuhaus, Klaus Gellert, Karsten Ridwelski, Marco Niedergethmann, Uwe Pelzer, Jens Stieler, M. Arning, Bernd Dörken and Marianne Sinn and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Helmut Oettle

146 papers receiving 8.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer

2007 1.8k citations Helmut Oettle, P. Neuhaus et al. JAMA profile →
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer

2013 1.3k citations Helmut Oettle, P. Neuhaus et al. JAMA profile →
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer

2004 616 citations Helmut Oettle, Walter L. Vervenne et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Helmut Oettle	6.5k	2.3k	2.2k	2.2k	2.2k	149	8.2k
Ari David Baron	7.6k 1.2×	2.3k 1.0×	2.1k 0.9×	3.4k 1.5×	852 0.4×	71	12.9k
Ronnie Tung‐Ping Poon	2.3k 0.4×	3.4k 1.5×	2.2k 1.0×	1.7k 0.8×	3.7k 1.7×	78	11.0k
Alexander Reinthaller	2.2k 0.3×	2.1k 0.9×	933 0.4×	895 0.4×	1.3k 0.6×	273	7.2k
Baek‐Yeol Ryoo	4.8k 0.7×	2.1k 0.9×	1.4k 0.6×	3.3k 1.5×	1.8k 0.8×	349	10.1k
John Wong	3.2k 0.5×	5.7k 2.4×	1.9k 0.9×	2.9k 1.3×	4.4k 2.0×	116	13.3k
Jae‐Lyun Lee	6.2k 1.0×	4.7k 2.0×	1.7k 0.8×	5.2k 2.4×	723 0.3×	394	11.4k
Clara C. Chen	3.3k 0.5×	2.6k 1.1×	2.1k 1.0×	1.6k 0.7×	815 0.4×	99	8.9k
Sergio Ricci	2.7k 0.4×	1.9k 0.8×	592 0.3×	1.2k 0.6×	743 0.3×	62	5.5k
Keiichi Fujiwara	2.7k 0.4×	1.3k 0.6×	614 0.3×	1.4k 0.7×	856 0.4×	364	6.7k
César A. Moran	3.7k 0.6×	4.1k 1.8×	755 0.3×	4.3k 2.0×	2.7k 1.2×	404	12.4k

Countries citing papers authored by Helmut Oettle

Since Specialization

Citations

This map shows the geographic impact of Helmut Oettle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helmut Oettle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helmut Oettle more than expected).

Fields of papers citing papers by Helmut Oettle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helmut Oettle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helmut Oettle. The network helps show where Helmut Oettle may publish in the future.

Co-authorship network of co-authors of Helmut Oettle

This figure shows the co-authorship network connecting the top 25 collaborators of Helmut Oettle. A scholar is included among the top collaborators of Helmut Oettle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helmut Oettle. Helmut Oettle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sinn, Marianne, Uwe Pelzer, Hanno Riess, et al.. (2024). KRT81 and HNF1A expression in pancreatic ductal adenocarcinoma: investigation of predictive and prognostic value of immunohistochemistry‐based subtyping. The Journal of Pathology Clinical Research. 10(3). e12377–e12377. 1 indexed citations

Grützmann, Robert, Michael Ghadimi, Waldemar Uhl, et al.. (2023). Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for non-resectable locally advanced pancreatic cancer: First results of the CONKO-007 trial. Zeitschrift für Gastroenterologie. 61(8). e389–e389.

Sinn, M., Jan Budczies, Frédérik Damm, et al.. (2017). TP53 mutation predicts sensitivity to adjuvant gemcitabine in pancreatic cancer: Results from the CONKO-001 study. Annals of Oncology. 28. v251–v251. 3 indexed citations

Lohneis, Philipp, Marianne Sinn, Sven Bischoff, et al.. (2017). Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. European Journal of Cancer. 83. 290–301. 67 indexed citations

Sinn, M., Jana K. Striefler, Judith Lindner, et al.. (2014). SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study. Annals of Oncology. 25(5). 1025–1032. 63 indexed citations

Oettle, Helmut. (2014). Progress in the knowledge and treatment of advanced pancreatic cancer: From benchside to bedside. Cancer Treatment Reviews. 40(9). 1039–1047. 79 indexed citations

Oettle, Helmut, P. Neuhaus, Andreas Hochhaus, et al.. (2013). Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer. JAMA. 310(14). 1473–1473. 1274 indexed citations breakdown →

Arnold, Dirk, Rainer Fietkau, Susanna Hegewisch‐Becker, et al.. (2011). Gastrointestinale Tumore – interdisziplinäre Diskussion neuer Daten. Onkologie. 34(s3). 1–31. 7 indexed citations

Fietkau, Rainer, Volker Heinemann, Helmut Oettle, Wolfram Trudo Knoefel, & Andrea Tannapfel. (2010). Neue Daten zum Pankreaskarzinom. Onkologie. 33(4). 31–35. 4 indexed citations

10.

Hilbig, Andreas & Helmut Oettle. (2010). Adjuvant therapy of pancreatic cancer. Expert Review of Anticancer Therapy. 10(4). 485–491. 4 indexed citations

11.

Saif, Muhammad Wasif, Helmut Oettle, Walter L. Vervenne, et al.. (2009). Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas. The Cancer Journal. 15(4). 339–343. 44 indexed citations

12.

Staib, Ludger, et al.. (2008). Therapie des fortgeschrittenen Pankreaskarzinoms. Onkologie. 31(5). 29–31. 1 indexed citations

13.

Raguse, Jan-Dirk, Hans Joachim Gath, Helmut Oettle, & J. Bier. (2004). Interferon-induced remission of rapidly growing aggressive fibromatosis in the temporal fossa. International Journal of Oral and Maxillofacial Surgery. 33(6). 606–609. 17 indexed citations

14.

Przybylski, Grzegorz K., Helmut Oettle, W. Siegert, & Christian Schmidt. (2001). Novel T-cell receptor δ gene rearrangement involving a recombining element located 2.6 kb 3′ from the Vδ2 gene segment. Leukemia Research. 25(12). 1059–1065. 1 indexed citations

15.

Einsele, Hermann, Hartmut Bertz, J. Beyer, et al.. (2001). Epidemiologie und interventionelle Therapiestrategien infektiöser Komplikationen nach allogener Stammzelltransplantation. DMW - Deutsche Medizinische Wochenschrift. 126(45). 1278–1284. 5 indexed citations

16.

Schmidt, Christian, Helmut Oettle, Freimut Wilborn, et al.. (2000). Presence of human β- and γ-herpes virus DNA in Hodgkin’s disease. Leukemia Research. 24(10). 865–870. 12 indexed citations

17.

Schwella, N., D. Kingreen, Helmut Oettle, et al.. (1997). Peripheral Blood Progenitor Cell Collection during Hematopoietic Recovery following Autologous Blood Progenitor Cell Transplantation. Vox Sanguinis. 72(2). 118–120. 1 indexed citations

18.

Oettle, Helmut, Freimut Wilborn, Jason R. Jessen, et al.. (1994). Demonstration of cytomegalovirus after bone marrow transplantation by polymerase chain reaction, virus culture and antigen detection in buffy coat leukocytes.. PubMed. 13(1). 71–5. 27 indexed citations

19.

Schmidt, Christian A., et al.. (1994). Heterogeneity of V52 TCR 8 Gene Rearrangements in Acute Myeloid Leukemia. Leukemia & lymphoma. 16(1-2). 73–77. 3 indexed citations

20.

Przybylski, Grzegorz K., Helmut Oettle, W. D. Ludwig, W. Siegert, & Christian A. Schmidt. (1994). Molecular characterization of illegitimate TCRδ gene rearrangements in acute myeloid leukaemia. British Journal of Haematology. 87(2). 301–307. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact